<?xml version='1.0' encoding='utf-8'?>
<document id="3301148"><sentence text="Pharmacokinetic interactions of cimetidine 1987."><entity charOffset="32-42" id="DDI-PubMed.3301148.s1.e0" text="cimetidine" /></sentence><sentence text="The number of studies on drug interactions with cimetidine has increased at a rapid rate over the past 5 years, with many of the interactions being solely pharmacokinetic in origin"><entity charOffset="48-58" id="DDI-PubMed.3301148.s2.e0" text="cimetidine" /></sentence><sentence text=" Very few studies have investigated the clinical relevance of such pharmacokinetic interactions by measuring pharmacodynamic responses or clinical endpoints" /><sentence text=" Apart from pharmacokinetic studies, invariably conducted in young, healthy subjects, there have been a large number of in vitro and in vivo animal studies, case reports, clinical observations and general reviews on the subject, which is tending to develop an industry of its own accord" /><sentence text=" Nevertheless, where specific mechanisms have been considered, these have undoubtedly increased our knowledge on the way in which humans eliminate xenobiotics" /><sentence text=" There is now sufficient information to predict the likelihood of a pharmacokinetic drug-drug interaction with cimetidine and to make specific clinical recommendations"><entity charOffset="111-121" id="DDI-PubMed.3301148.s6.e0" text="cimetidine" /></sentence><sentence text=" Pharmacokinetic drug interactions with cimetidine occur at the sites of gastrointestinal absorption and elimination including metabolism and excretion"><entity charOffset="40-50" id="DDI-PubMed.3301148.s7.e0" text="cimetidine" /></sentence><sentence text=" Cimetidine has been found to reduce the plasma concentrations of ketoconazole, indomethacin and chlorpromazine by reducing their absorption"><entity charOffset="1-11" id="DDI-PubMed.3301148.s8.e0" text="Cimetidine" /><entity charOffset="66-78" id="DDI-PubMed.3301148.s8.e1" text="ketoconazole" /><entity charOffset="80-92" id="DDI-PubMed.3301148.s8.e2" text="indomethacin" /><entity charOffset="97-111" id="DDI-PubMed.3301148.s8.e3" text="chlorpromazine" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e0" e2="DDI-PubMed.3301148.s8.e0" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e0" e2="DDI-PubMed.3301148.s8.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e0" e2="DDI-PubMed.3301148.s8.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e0" e2="DDI-PubMed.3301148.s8.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e1" e2="DDI-PubMed.3301148.s8.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e1" e2="DDI-PubMed.3301148.s8.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e1" e2="DDI-PubMed.3301148.s8.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e2" e2="DDI-PubMed.3301148.s8.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s8.e2" e2="DDI-PubMed.3301148.s8.e3" /></sentence><sentence text=" In the case of ketoconazole the interaction was clinically important"><entity charOffset="16-28" id="DDI-PubMed.3301148.s9.e0" text="ketoconazole" /></sentence><sentence text=" Cimetidine does not inhibit conjugation mechanisms including glucuronidation, sulphation and acetylation, or deacetylation or ethanol dehydrogenation"><entity charOffset="1-11" id="DDI-PubMed.3301148.s10.e0" text="Cimetidine" /><entity charOffset="127-134" id="DDI-PubMed.3301148.s10.e1" text="ethanol" /><pair ddi="false" e1="DDI-PubMed.3301148.s10.e0" e2="DDI-PubMed.3301148.s10.e0" /><pair ddi="false" e1="DDI-PubMed.3301148.s10.e0" e2="DDI-PubMed.3301148.s10.e1" /></sentence><sentence text=" It binds to the haem portion of cytochrome P-450 and is thus an inhibitor of phase I drug metabolism (i" /><sentence text="e" /><sentence text=" hydroxylation, dealkylation)" /><sentence text=" Although generally recognised as a nonspecific inhibitor of this type of metabolism, cimetidine does demonstrate some degree of specificity"><entity charOffset="86-96" id="DDI-PubMed.3301148.s14.e0" text="cimetidine" /></sentence><sentence text=" To date, theophylline 8-oxidation, tolbutamide hydroxylation, ibuprofen hydroxylation, misonidazole demethylation, carbamazepine epoxidation, mexiletine oxidation and steroid hydroxylation have not been shown to be inhibited by cimetidine in humans but the metabolism of at least 30 other drugs is affected"><entity charOffset="10-22" id="DDI-PubMed.3301148.s15.e0" text="theophylline" /><entity charOffset="36-47" id="DDI-PubMed.3301148.s15.e1" text="tolbutamide" /><entity charOffset="63-72" id="DDI-PubMed.3301148.s15.e2" text="ibuprofen" /><entity charOffset="88-100" id="DDI-PubMed.3301148.s15.e3" text="misonidazole" /><entity charOffset="116-129" id="DDI-PubMed.3301148.s15.e4" text="carbamazepine" /><entity charOffset="143-153" id="DDI-PubMed.3301148.s15.e5" text="mexiletine" /><entity charOffset="168-175" id="DDI-PubMed.3301148.s15.e6" text="steroid" /><entity charOffset="229-239" id="DDI-PubMed.3301148.s15.e7" text="cimetidine" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e0" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e0" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e1" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e2" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e3" e2="DDI-PubMed.3301148.s15.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e3" e2="DDI-PubMed.3301148.s15.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e3" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e3" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e3" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e4" e2="DDI-PubMed.3301148.s15.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e4" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e4" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e4" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e5" e2="DDI-PubMed.3301148.s15.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e5" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e5" e2="DDI-PubMed.3301148.s15.e7" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e6" e2="DDI-PubMed.3301148.s15.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s15.e6" e2="DDI-PubMed.3301148.s15.e7" /></sentence><sentence text=" Recent evidence indicates negligible effects of cimetidine on liver blood flow"><entity charOffset="49-59" id="DDI-PubMed.3301148.s16.e0" text="cimetidine" /></sentence><sentence text=" Cimetidine reduces the renal clearance of drugs which are organic cations, by competing for active tubular secretion in the proximal tubule of the kidney, reducing the renal clearances of procainamide, ranitidine, triamterene, metformin, flecainide and the active metabolite N-acetylprocainamide"><entity charOffset="1-11" id="DDI-PubMed.3301148.s17.e0" text="Cimetidine" /><entity charOffset="189-201" id="DDI-PubMed.3301148.s17.e1" text="procainamide" /><entity charOffset="203-213" id="DDI-PubMed.3301148.s17.e2" text="ranitidine" /><entity charOffset="215-226" id="DDI-PubMed.3301148.s17.e3" text="triamterene" /><entity charOffset="228-237" id="DDI-PubMed.3301148.s17.e4" text="metformin" /><entity charOffset="239-249" id="DDI-PubMed.3301148.s17.e5" text="flecainide" /><entity charOffset="276-296" id="DDI-PubMed.3301148.s17.e6" text="N-acetylprocainamide" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e0" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e0" e2="DDI-PubMed.3301148.s17.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e1" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e1" e2="DDI-PubMed.3301148.s17.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e2" e2="DDI-PubMed.3301148.s17.e2" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e2" e2="DDI-PubMed.3301148.s17.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e2" e2="DDI-PubMed.3301148.s17.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e2" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e2" e2="DDI-PubMed.3301148.s17.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e3" e2="DDI-PubMed.3301148.s17.e3" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e3" e2="DDI-PubMed.3301148.s17.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e3" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e3" e2="DDI-PubMed.3301148.s17.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e4" e2="DDI-PubMed.3301148.s17.e4" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e4" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e4" e2="DDI-PubMed.3301148.s17.e6" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e5" e2="DDI-PubMed.3301148.s17.e5" /><pair ddi="false" e1="DDI-PubMed.3301148.s17.e5" e2="DDI-PubMed.3301148.s17.e6" /></sentence><sentence text=" This previously unrecognised form of drug interaction with cimetidine may be clinically important for both parent drug, and metabolites which may be active"><entity charOffset="60-70" id="DDI-PubMed.3301148.s18.e0" text="cimetidine" /></sentence><sentence text="(ABSTRACT TRUNCATED AT 400 WORDS)" /></document>